Tevogen Bio Holdings ( (TVGN) ) has released a notification of late filing.
Tevogen Bio Holdings Inc. has announced a delay in filing its Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The delay is primarily due to the company’s recent change in third-party service providers for its internal accounting and financial reporting functions, necessitating additional time to finalize its financial statements. The company expects to file the report within the 15-day extension period allowed under Rule 12b-25. Tevogen Bio anticipates a significant change in its financial results, projecting a net loss of approximately $13.7 million for 2024, a substantial improvement from the $60.5 million net loss in 2023. This change is largely attributed to stock-based compensation expenses and transaction costs related to a business combination, partially offset by changes in the fair value of convertible promissory notes. The company is committed to finalizing its financial statements and maintaining compliance, as indicated by CEO Ryan Saadi’s signature on the notification.
More about Tevogen Bio Holdings
YTD Price Performance: 1.89%
Average Trading Volume: 2,080,055
Technical Sentiment Signal: Buy
Current Market Cap: $210.1M
See more insights into TVGN stock on TipRanks’ Stock Analysis page.